Nitric oxide-mediated signals have been suggested to regulate the activity of
caspases negatively, yet literature has provided little direct evidence. We show in this paper that
cytokines and
nitric-oxide synthase (NOS) inhibitors regulate S-nitrosation of an initiator
caspase,
procaspase-9, in a human
colon adenocarcinoma cell line, HT-29. A NOS inhibitor, N(G)-methyl-
l-arginine, enhanced the
tumor necrosis factor-alpha (
TNF-alpha)-induced cleavage of
procaspase-9,
procaspase-3, and
poly-(ADP-ribose) polymerase, as well as the level of apoptosis. N(G)-Methyl-
l-arginine, however, did not affect the cleavage of
procaspase-8. These results suggest that
nitric oxide regulates the cleavage of
procaspase-9 and its downstream
proteins and, subsequently, apoptosis in HT-29 cells. Labeling S-nitrosated cysteines with a
biotin tag enabled us to reveal S-nitrosation of endogenous
procaspase-9 that was immunoprecipitated from the HT-29 cell extracts. Furthermore, the treatment with
TNF-alpha, as well as NOS inhibitors, decreased
interferon-gamma-induced S-nitrosation in
procaspase-9. Our results show that S-nitrosation of endogenous
procaspase-9 occurs in the HT-29 cells under normal conditions and that denitrosation of
procaspase-9 enhances its cleavage and consequent apoptosis. We, therefore, suggest that S-nitrosation regulates activation of endogenous
procaspase-9 in HT-29 cells.